{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:50:33Z","timestamp":1792504233923,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.neubiorev.2023.105149","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T11:22:07Z","timestamp":1680088927000},"page":"105149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-8075","authenticated-orcid":false,"given":"Samuele","family":"Cortese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"McGinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"H\u00f8jlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Apter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Banaschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Buitelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Castro-Fornieles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna","family":"Gr\u00fcnblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Katrine","family":"Pagsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Persico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Purper-Ouakil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramala","family":"Santosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Simonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyris","family":"Stringaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Walitza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Wohlfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Zalsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zuddas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neubiorev.2023.105149_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nn.4276","article-title":"Neurobiology of social behavior abnormalities in autism and Williams syndrome","volume":"19","author":"Barak","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/YCO.0000000000000775","article-title":"Novel treatments in autism spectrum disorder","volume":"35","author":"Baribeau","year":"2022","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105149_bib3","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105149_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/wps.21056","article-title":"The future of psychopharmacology: a critical appraisal of ongoing phase 2\/3 trials, and of some trends aiming to de-risk trial programmes of novel agents","volume":"22","author":"Correll","year":"2023","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/wps.20881","article-title":"Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review","volume":"20","author":"Correll","year":"2021","journal-title":"World Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2023.105149_bib6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMra1917069","article-title":"Pharmacologic treatment of attention deficit-hyperactivity disorder","volume":"383","author":"Cortese","year":"2020","journal-title":"New Engl. J. Med"},{"issue":"12","key":"10.1016\/j.neubiorev.2023.105149_bib7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2352-4642(22)00312-1","article-title":"Treatment of ADHD in preschool children","volume":"6","author":"Cortese","year":"2022","journal-title":"Lancet Child Adolesc. Health"},{"issue":"10","key":"10.1016\/j.neubiorev.2023.105149_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40263-021-00848-3","article-title":"A practical, evidence-informed approach to managing stimulant-refractory attention deficit hyperactivity disorder (ADHD)","volume":"35","author":"Cortese","year":"2021","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.neubiorev.2023.105149_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jaac.2022.06.002","article-title":"The neuroscience-based nomenclature child & adolescent (NbN C&A) for psychotropic medications: innovation in progress","volume":"61","author":"Cortese","year":"2022","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105149_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/wps.21037","article-title":"Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review","volume":"22","author":"Cortese","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105149_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euroneuro.2021.02.020","article-title":"A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders","volume":"48","author":"D\u00edaz-Caneja","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"178(4)","key":"10.1016\/j.neubiorev.2023.105149_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.ajp.2020.20010018","article-title":"Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial","volume":"1","author":"Dwyer","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105149_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41380-021-01134-w","article-title":"Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis","volume":"27","author":"Faraone","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2352-4642(22)00316-9","article-title":"Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children,adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis","volume":"7","author":"Farhat","year":"2023","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.neubiorev.2023.105149_bib15","unstructured":"Food and Drug Administraton. \u3008https:\/\/www.fda.gov\/media\/161190\/download\u3009. Accessed: February 2023."},{"issue":"9732","key":"10.1016\/j.neubiorev.2023.105149_bib16","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(10)60587-9","article-title":"Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial","volume":"375","author":"Green","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105149_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jcpp.13014","article-title":"Practitioner Review: Assessment and treatment of preschool children with attention-deficit\/hyperactivity disorder","volume":"60","author":"Halperin","year":"2019","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaac.2013.11.009","article-title":"Alpha-2 agonists for attention-deficit\/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy","volume":"53","author":"Hirota","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105149_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ijnp\/pyac009","article-title":"Functional neuroimaging correlates of placebo response in patients with depressive or anxiety disorders: a systematic review","volume":"25","author":"Huneke","year":"2022","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105149_bib20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1176\/appi.ajp.160.9.1566","article-title":"A new approach to integrating data from multiple informants in psychiatric assessment and research: mixing and matching contexts and perspectives","volume":"160","author":"Kraemer","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105149_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2017.08.010","article-title":"Pharmacotherapy of emotional dysregulation in adults with ADHD: a systematic review and meta-analysis","volume":"84","author":"Lenzi","year":"2018","journal-title":"Neurosci. Biobehav Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjp.bp.111.096594","article-title":"Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses","volume":"200","author":"Leucht","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2023.105149_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.292.7.807","article-title":"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for Adolescents With Depression Study (TADS) randomized controlled trial","volume":"292","author":"March","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2023.105149_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jpsychires.2022.03.018","article-title":"The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: a systematic review","volume":"149","author":"McKenzie","year":"2022","journal-title":"J. Psychiatr. Res"},{"issue":"7","key":"10.1016\/j.neubiorev.2023.105149_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14737175.2019.1628640","article-title":"Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD","volume":"19","author":"Nageye","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neubiorev.2023.105149_bib26","unstructured":"NICE, 2013. National Institute for Health and Care Excellence. Psychosis and schizophrenia in children and young people: recognition and management. Accessed at \u3008https:\/\/www.nice.org.uk\/guidance\/cg155\u3009, on January 11, 2023."},{"key":"10.1016\/j.neubiorev.2023.105149_bib27","unstructured":"NICE, 2019b. Attention deficit hyperactivity disorder: diagnosis and management. Accessed a\u3008https:\/\/www.nice.org.uk\/guidance\/ng87\u3009 on January 11, 2023."},{"key":"10.1016\/j.neubiorev.2023.105149_bib28","unstructured":"National Institute for Health and Care Excellence (NICE), 2019a. Depression in children and young people: identification and management. Accessed at \u3008https:\/\/www.nice.org.uk\/guidance\/ng134\u3009, on January 11, 2023."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105149_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaac.2016.12.013","article-title":"Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis","volume":"56","author":"Pagsberg","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2023.105149_bib30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.euroneuro.2011.09.007","article-title":"Placebo effect in child and adolescent psychiatric trials","volume":"22","author":"Parellada","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.neubiorev.2023.105149_bib31","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.euroneuro.2015.06.009","article-title":"Unmet needs in paediatric psychopharmacology: present scenario and future perspectives","volume":"25","author":"Persico","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105149_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/wps.20800","article-title":"RDoC at 10: changing the discourse for psychopathology","volume":"19","author":"Sanislow","year":"2020","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaac.2013.11.005","article-title":"Efficacy and safety of atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression","volume":"53","author":"Schwartz","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105149_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13229-020-00372-z","article-title":"Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis","volume":"11","author":"Siafis","year":"2020","journal-title":"Mol. Autism"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105149_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","article-title":"Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies","volume":"27","author":"Solmi","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105149_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-022-01630-7","article-title":"Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries","author":"Solmi","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105149_bib38","first-page":"139","article-title":"Management of complex co-occurring psychiatric disorders and high-risk behaviors in adolescence","volume":"18","author":"Welsh","year":"2020","journal-title":"Focus (Am. Psychiatr. Publ. )"},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105149_bib39","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/jcpp.12556","article-title":"Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review","volume":"57","author":"Whittington","year":"2016","journal-title":"J. Child Psychol. Psychiatry"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423001185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423001185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:27:24Z","timestamp":1758968844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763423001185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":39,"alternative-id":["S0149763423001185"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105149","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105149"}}